Xiamen, China Xiamen Changrong Investment Management is the famous VC, which was founded in 2007. The main department of described VC is located in the Xiamen. The fund was located in Asia if to be more exact in China.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Xiamen Changrong Investment Management, startups are often financed by Qiaojing Capital, Gaorong Capital, Yijing Capital. The meaningful sponsors for the fund in investment in the same round are Yingqi Investment, Yijing Capital, StarVC. In the next rounds fund is usually obtained by Yijing Capital.
The fund was created by Jiayu Cai, Lin Sun.
This Xiamen Changrong Investment Management works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2019.
Among the most popular portfolio startups of the fund, we may highlight Viva Biotech, iyiou.com. Among the most successful fund investment fields, there are Service Industry, Consulting. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anvil Partners | England, London, United Kingdom |
| ASOS | England, London, United Kingdom |
| Block Hype | China, Guangdong, Shenzhen |
| DaSheng Capital | - |
| Mobile Dreams Factory | Community of Madrid, Madrid, Spain |
| Spirox | California, Sunnyvale, United States |
| Tenaya Capital | California, Portola Valley, United States |
| the Etchart Group | - |
| TNInvestco | Nashville, Tennessee, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Amberstone Biosciences | $12M | 03 Jan 2022 | Laguna Hills, California, United States | ||
Anji Pharmaceuticals | $70M | 28 Sep 2021 | Cambridge, Massachusetts, United States | ||
Elgia Therapeutics | 15 Jun 2020 | San Diego, California, United States | |||
EO Company | $9M | 03 Apr 2018 | Dongcheng District, Beijing, China | ||
Onlyou | $45M | 11 Dec 2017 | Selangor |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Amberstone Biosciences | $12M | 03 Jan 2022 | Laguna Hills, California, United States | ||
Anji Pharmaceuticals | $70M | 28 Sep 2021 | Cambridge, Massachusetts, United States | ||
Elgia Therapeutics | 15 Jun 2020 | San Diego, California, United States | |||
EO Company | $9M | 03 Apr 2018 | Dongcheng District, Beijing, China | ||
Onlyou | $45M | 11 Dec 2017 | Selangor |
